Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

XBI

State Street SPDR S&P Biotech ETF

Dec 05 • 01:36PM ET

123.23

-0.02 -0.02 %

Financial • Exchange Traded Fund • USA • NYSE

Held by: QVOY MDAA GDMA PSTR

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	24.13%	Total Holdings	135	Perf Week	0.06%
Sponsor	State Street (SPDR)	ETF Type		Tags	equity	Return% 3Y	15.57%	AUM	7.67B	Perf Month	12.84%
Fund Family		Bond Type		Tags	biotechnology	Return% 5Y	-1.22%	NAV/sh		Perf Quarter	30.50%
Index	S&P Biotechnology Select Industry Index	Average Maturity		Tags	-	Return% 10Y		52W High	123.61 -0.31%	Perf Half Y	46.25%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	66.66 84.86%	Perf YTD	36.83%
Active/Passive		Quant Type		Tags	-	Flows% 1M	6.89%	Volatility	1.94% 2.34%	Perf Year	26.14%
Dividend TTM	0.04 (0.03%)	ESG Type		Tags	-	Flows% 3M	7.12%	ATR (14)	2.63	Perf 3Y	47.37%
Dividend Ex-Date	Sep 22, 2025	Dividend Type		Sector/Theme		Flows% YTD	-7.33%	RSI (14)	68.42	Perf 5Y	-7.48%
Dividend Gr. 3/5Y	49.26% 113.47%	Structure Type		Region		Flows% 1Y		Beta	0.86	Perf 10Y	69.69%
Expense	0.35%	Growth/Value		SMA20	5.25%	Flows% 3Y		Rel Volume	0.62	Prev Close	123.25
Inverse/Leveraged		Market Cap		SMA50	11.14%	Flows% 5Y		Avg Volume	10.79M	Price	123.23
IPO	Feb 06, 2006	Option/Short	Yes / Yes	SMA200	34.63%	Trades		Volume	4,319,569	Change	-0.02%

Today 10:01AM	Biotech ETF (XBI) Hits New 52-Week High (Zacks)
Dec-04-25 11:13AM	More Changes at FDA Prompt Pushback From Former Leaders (Barrons.com)
11:10AM	The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch. (Barrons.com)
05:30AM	Turmoil at the FDA Threatens Biotech Recovery (The Wall Street Journal)
Dec-01-25 11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
09:59AM	Loading…
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
Nov-20-25 01:50PM	3 Biotech Stocks Wall Street Analysts Predict Will More Than Double (Barchart)
Nov-19-25 06:20AM	Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? (Zacks)
Nov-18-25 04:21PM	Why biotech and drug stocks are on the mend even though the rest of the market is hurting (MarketWatch)
Nov-17-25 09:18PM	Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. (Motley Fool)
01:20PM	Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion (Barrons.com)
08:09AM	Biotech ETF (XBI) Hits New 52-Week High (Zacks)
Nov-14-25 11:30AM	Merck Is Paying Up for Flu Biotech as M&A Spree Continues (Barrons.com)
Nov-12-25 01:47PM	The FDA Has a New Drug Chief. What it Means for Biotech Stocks. (Barrons.com)
Nov-06-25 04:09PM	Moderna Cuts Costs As Covid Vaccine Sales Decline; Shares Rise (Investor's Business Daily)
01:04PM	Loading…
Oct-30-25 01:04PM	Investor focus shifts to late-stage development in biotech, expert says (Clinical Trials Arena)
09:00AM	Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
Oct-27-25 11:16AM	Novartis Avidity Deal Is a Green Light for Biotech Rally (Barrons.com)
Oct-24-25 04:44PM	Biotech Stocks Returned To Health And Offered Multiple Entries (Investor's Business Daily)
Oct-23-25 11:15AM	Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back (Barrons.com)
Oct-21-25 07:53AM	Analyst Says He's Buying This Biotech ETF, Predicts 'Multi-Year' Breakout (Insider Monkey)
Oct-17-25 04:21PM	The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. (Investor's Business Daily)
02:02PM	Biotech Is Finally Rallying. Why Mizuho's Jared Holz Is Optimistic This Time. (Barrons.com)
Oct-15-25 10:45AM	Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential (Investing.com)
Oct-13-25 03:24PM	Trump's AstraZeneca Deal Echoes Pfizer Pact. Big Pharma's Political Headaches Are Easing. (Barrons.com)
06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
05:30AM	Why Biotechs Rally Can Last This Time (The Wall Street Journal)
Oct-10-25 08:18PM	Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. (Barrons.com)
12:19PM	Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. (Barrons.com)
Oct-09-25 11:17AM	Novo Nordisk Is Buying Akero Therapeutics. Its More Good News for Biotech Stocks. (Barrons.com)
11:33AM	Loading…
Oct-06-25 11:33AM	Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. (Barrons.com)
Oct-02-25 08:00AM	Gilead's Lost Decade Is Over. It's Time to Buy the Stock. (Barrons.com)
Oct-01-25 07:27AM	Unlocking Cures: How AI is Reshaping Cancer Research & Healthcare ETFs? (Zacks)
Sep-23-25 01:13PM	Biotech Stocks Rally. 3 Favorite Plays From the Charts. (Barrons.com)
Sep-16-25 06:20AM	Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? (Zacks)
Sep-14-25 05:30AM	Biotech stocks: Who wins and who loses if RFK, Jr. goes (Investing.com)
Sep-11-25 01:22PM	Biotechs nuclear winter not over yetWolfe (Investing.com)
05:00AM	As the Fed Pivots, These 3 ETFs Are Positioned to Outperform (Motley Fool)
Sep-09-25 02:22PM	Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade. (Barrons.com)
Sep-03-25 02:20PM	Sell Your 'Junk' Stocks. Their Rallies Are Over. (Barrons.com)
Aug-22-25 07:50AM	Suze Orman is known for money advice - now she's sharing her stock picks and biggest investing mistake (MarketWatch)
Aug-21-25 05:05AM	Biogen Stock: Analyst Estimates & Ratings (Barchart)
Aug-15-25 10:04AM	This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine (Investor's Business Daily)
Aug-12-25 06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
Aug-11-25 03:24PM	Leadership Turmoil at FDA Adds to Difficult Stretch for Biotech Investors (Barrons.com)
02:00AM	Gilead Stock Is Closing In on an All-Time High. The Case for More Upside. (Barrons.com)
Aug-04-25 01:01AM	BBH- A Biotech Fund That's Ripe for a Major Turnaround (MoneyShow)
Jul-30-25 01:14PM	Top FDA Official's Surprise Departure Means More Uncertainty for Biotech (Barrons.com)
12:37PM	Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. (Barrons.com)
Jul-28-25 04:13PM	Biotech stocks dip as Trump administration mulls patent fee overhaul (Investing.com)
Jul-16-25 04:05PM	Will Trump's Looming Tariffs Affect Pharma Profits In The Second Half Of 2025? (Investor's Business Daily)
10:23AM	Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn (Investor's Business Daily)
Jul-14-25 08:51AM	Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. (Barrons.com)
01:30AM	Biotech Stocks Are Ready to Rebound. 3 to Watch Now. (Barrons.com)
Jul-10-25 06:20AM	Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? (Zacks)
Jul-09-25 11:41AM	Wall Street waves off Trump's 200% pharma tariff threat (Yahoo Finance)
Jul-08-25 01:58PM	Trump plans tariffs on chips, drugs (Investing.com)
Jun-30-25 06:20AM	Should You Invest in the VanEck Biotech ETF (BBH)? (Zacks)
Jun-20-25 11:56AM	Gene Therapy Stocks Fall as FDA Pushes Out Another Top Regulator (Barrons.com)
11:56AM	Gene Therapy Stocks Fall Amid More Turmoil at FDA (Barrons.com)
Jun-17-25 12:57PM	Citi initiates coverage on biotech amid improving sentiment in sector (Investing.com)
06:20AM	Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? (Zacks)
Jun-12-25 06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
Jun-09-25 06:20AM	Should You Invest in the iShares Biotechnology ETF (IBB)? (Zacks)
Jun-06-25 01:30AM	Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments (Barrons.com)
May-27-25 06:20AM	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? (Zacks)
May-20-25 06:20AM	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? (Zacks)
May-13-25 06:43AM	Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft (Zacks)
May-12-25 01:14PM	Drugmakers Spared Worst-Case Drug Pricing Scenario for Now (The Wall Street Journal)
08:58AM	Surprise Breakthrough: US-China Talks Spark Market Rally (Zacks)
May-06-25 06:20AM	Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? (Zacks) -6.63%
May-02-25 06:10PM	Leveraged ETFs Report And Focus On SPUU: Not A Long-Term Investment (Seeking Alpha)
05:17AM	Alexandria Real Estate Equities Looks Juicy But Uncertainty Keeps Me Sidelined (Seeking Alpha)
03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
May-01-25 12:34PM	3 Market Predictions For May (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-29-25 06:20AM	Should You Invest in the VanEck Biotech ETF (BBH)? (Zacks)
Apr-25-25 12:09PM	Healthcare sector under pressure as market weighs Trump impact (Yahoo Finance Video)
Apr-24-25 06:20AM	Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? (Zacks)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-22-25 02:54PM	Enliven Therapeutics: Awaiting Additional Trial Data (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-17-25 10:28AM	89bio: Primary Asset Targeting 2 Potential Indications And Is In Late-Stage Development (Seeking Alpha)
06:20AM	Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? (Zacks)
Apr-16-25 06:20AM	Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? (Zacks)
Apr-10-25 04:36PM	Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets (Motley Fool)
Apr-09-25 12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha) +7.28%
06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
Apr-07-25 06:20AM	Should You Invest in the iShares Biotechnology ETF (IBB)? (Zacks)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.73%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 12:15PM	3 Market Predictions For April (Seeking Alpha)
08:00AM	UDOW And Leveraged ETFs Drift Update (Seeking Alpha)
05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-31-25 11:05AM	Biotech Investors Rush for the Exits After FDA Official Resigns: Heard on the Street (The Wall Street Journal)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-24-25 01:56PM	Argenx: The Magic May Be Already Priced In (SeekingAlpha)
06:20AM	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? (Zacks)
Mar-23-25 07:18AM	Wall Street Week Ahead (SeekingAlpha)

SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

open in yahoo | open in marketwatch | open in google

Cyber Swan Sale

50% Off Elite

XBI

State Street SPDR S&P Biotech ETF

Upgrade your FINVIZ experience